(Q61907402)

English

Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Dose Cohort Study to Evaluate the Efficacy and Safety of Twelve Once-weekly Subcutaneous Doses of PB-119 to Patients With Type 2 Diabetes Mellitus (T2DM) Not Well-controlled by Metformin Monotherapy (English)

0 references

medical condition

diabetes

0 references

country

United States of America

0 references

start time

13 June 2018

0 references

end time

1 April 2019